Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
How can cognitive reserve in multiple sclerosis inform clinical care?
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Diversity Matters: A Revised Guide to Myelination.
Accuracy and reaction time in recognition of facial emotions in people with multiple sclerosis.
Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
[Immunomodulatory effect of Huangqi glycoprotein on mice with experimental autoimmune encephalomyelitis].
MS Trust critical of guidance on multiple sclerosis.
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Multiple sclerosis and cancer: When two wrongs make a right?
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Neurology in the developing world.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Refining a Web-based goal assessment interview: item reduction based on reliability and predictive validity.
Pages
« first
‹ previous
…
607
608
609
610
611
612
613
614
615
…
next ›
last »